{"filing":{"accession_number":"0001193125-26-245235","cik":"0001802255","ticker":"GRDN","company_name":"Guardian Pharmacy Services, Inc.","form":"8-K","filing_date":"2026-05-28","report_date":null,"primary_document":"d139098d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1802255/000119312526245235/d139098d8k.htm"},"events":[{"id":8436,"run_id":7402,"accession_number":"0001193125-26-245235","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"Guardian Pharmacy Services entered into the Eighth Amendment to its Loan and Security Agreement on May 21, 2026, extending the maturity date to May 21, 2030, adding incremental borrowing capacity of up to $40 million (potentially reaching $80 million total), and modifying key financial covenants.","company_name":"Guardian Pharmacy Services, Inc.","ticker":"GRDN","filing_date":"2026-05-28","form":"8-K","submitted_at":null,"items":[{"id":2323,"accession_number":"0001193125-26-245235","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Guardian Pharmacy Services entered into the Eighth Amendment to its Loan and Security Agreement on May 21, 2026, which materially modifies the company's credit facility. The amendment extends the maturity date to May 21, 2030, permits incremental borrowing capacity of up to $40 million (potentially reaching $80 million total), and modifies key financial covenants. While technically a loan amendment rather than a traditional M\u0026A transaction, this represents a material definitive agreement that affects the company's capital structure and financial flexibility, warranting disclosure under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:38:35.141050+00:00","company_name":"","ticker":null,"filing_date":""},{"id":2324,"accession_number":"0001193125-26-245235","item_number":"2.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation, with details incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. Item 1.01 typically covers material acquisitions or dispositions, which would suggest ma_activity, but Item 2.03 could also relate to debt issuance, covenant breaches, or other financial arrangements. Given the ambiguity and the reference structure, classifying as other_material is most defensible pending review of Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:38:35.141050+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2323,"accession_number":"0001193125-26-245235","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"Guardian Pharmacy Services entered into the Eighth Amendment to its Loan and Security Agreement on May 21, 2026, which materially modifies the company's credit facility. The amendment extends the maturity date to May 21, 2030, permits incremental borrowing capacity of up to $40 million (potentially reaching $80 million total), and modifies key financial covenants. While technically a loan amendment rather than a traditional M\u0026A transaction, this represents a material definitive agreement that affects the company's capital structure and financial flexibility, warranting disclosure under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:38:35.141050+00:00","company_name":"Guardian Pharmacy Services, Inc.","ticker":"GRDN","filing_date":"2026-05-28"},{"id":2324,"accession_number":"0001193125-26-245235","item_number":"2.03","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.45,"reasoning":"Item 2.03 discloses creation of a direct financial obligation, with details incorporated by reference from Item 1.01. Without access to Item 1.01's content, the specific nature of the obligation cannot be determined. Item 1.01 typically covers material acquisitions or dispositions, which would suggest ma_activity, but Item 2.03 could also relate to debt issuance, covenant breaches, or other financial arrangements. Given the ambiguity and the reference structure, classifying as other_material is most defensible pending review of Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-29T02:38:35.141050+00:00","company_name":"Guardian Pharmacy Services, Inc.","ticker":"GRDN","filing_date":"2026-05-28"}]}